We found a higher, although of borderline significance, incidence of brain metastases (BMs) in patients with EGFR mutations compared with WT.
← all excerpts
Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities.
1
—
—